Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 121,257,392
  • Shares Outstanding, K 253,719
  • Annual Sales, $ 11,020 M
  • Annual Income, $ -535,600 K
  • EBIT $ 3,993 M
  • EBITDA $ 4,201 M
  • 60-Month Beta 0.30
  • Price/Sales 10.53
  • Price/Cash Flow N/A
  • Price/Book 6.97

Options Overview Details

View History
  • Implied Volatility 40.01% (-0.17%)
  • Historical Volatility 29.57%
  • IV Percentile 98%
  • IV Rank 71.41%
  • IV High 47.19% on 04/08/25
  • IV Low 22.08% on 08/27/25
  • Expected Move (DTE 6) 26.20 (5.48%)
  • Put/Call Vol Ratio 1.45
  • Today's Volume 4,639
  • Volume Avg (30-Day) 3,830
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 40,440
  • Open Int (30-Day) 39,289
  • Expected Range 451.72 to 504.12

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 32 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 4.40
  • Number of Estimates 10
  • High Estimate 4.77
  • Low Estimate 4.00
  • Prior Year 3.54
  • Growth Rate Est. (year over year) +24.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
429.00 +11.40%
on 01/20/26
487.52 -1.97%
on 01/07/26
+9.54 (+2.04%)
since 01/06/26
3-Month
406.67 +17.52%
on 11/07/25
487.52 -1.97%
on 01/07/26
+61.67 (+14.82%)
since 11/06/25
52-Week
362.50 +31.84%
on 08/11/25
519.68 -8.04%
on 03/14/25
-3.24 (-0.67%)
since 02/06/25

Most Recent Stories

More News
3 Market-Beating Stocks Worth Investigating

3 Market-Beating Stocks Worth Investigating

WWD : 388.50 (+3.10%)
VRTX : 477.92 (+4.17%)
AJG : 241.58 (-0.48%)
Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs

Experienced industry leader brings extensive expertise in leading breakthrough therapies through clinical development to marketing approval

GBIO : 5.34 (-6.97%)
MSCLF : 0.9230 (+1.41%)
VRTX : 477.92 (+4.17%)
MSCL.TO : 16.05 (-0.62%)
1 Healthcare Stock to Consider Right Now and 2 We Brush Off

1 Healthcare Stock to Consider Right Now and 2 We Brush Off

OMCL : 37.07 (-5.14%)
SUPN : 51.65 (+4.62%)
VRTX : 477.92 (+4.17%)
Reflecting On Therapeutics Stocks’ Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX)

Reflecting On Therapeutics Stocks’ Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX)

VRTX : 477.92 (+4.17%)
Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, after the financial markets close. The company...

VRTX : 477.92 (+4.17%)
Unpacking Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

Unpacking Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

VRTX : 477.92 (+4.17%)
3 Profitable Stocks with Open Questions

3 Profitable Stocks with Open Questions

IRDM : 20.00 (+4.55%)
VRTX : 477.92 (+4.17%)
BFAM : 86.08 (-2.98%)
Here's What to Expect From Vertex Pharmaceuticals' Next Earnings Report

Vertex Pharmaceuticals is scheduled to post its fourth-quarter results soon, and analysts project a double-digit earnings growth

ABT : 110.83 (+1.60%)
XLV : 157.71 (+1.85%)
$SPX : 6,932.30 (+1.97%)
VRTX : 477.92 (+4.17%)
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor meetings in January, including the company’s scheduled webcast from the 44th...

VRTX : 477.92 (+4.17%)
Stocks making big moves yesterday: Herbalife, Vertex Pharmaceuticals, Micron, Amkor, and Palantir Technologies

Stocks making big moves yesterday: Herbalife, Vertex Pharmaceuticals, Micron, Amkor, and Palantir Technologies

HLF : 16.99 (+1.80%)
MU : 394.69 (+3.08%)
VRTX : 477.92 (+4.17%)
AMKR : 49.36 (+11.50%)
PLTR : 135.90 (+4.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which...

See More

Key Turning Points

3rd Resistance Point 503.75
2nd Resistance Point 491.01
1st Resistance Point 484.47
Last Price 477.92
1st Support Level 465.19
2nd Support Level 452.45
3rd Support Level 445.91

See More

52-Week High 519.68
Last Price 477.92
Fibonacci 61.8% 459.64
Fibonacci 50% 441.09
Fibonacci 38.2% 422.54
52-Week Low 362.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar